The largest genetic analysis of stuttering has demonstrated a clear genetic basis for the speech disorder, highlighting ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, ...

After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.

DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The ...

Our previous report on the Chapter 11 case of 23andMe discussed the Sale Order entered by the Bankruptcy Court on June 27, ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

When popular genetic testing company 23andMe filed for bankruptcy earlier this year and announced it was for sale, privacy experts and consumer advocates raised concerns over the future of the ...

A U.S. district judge put on hold the bankruptcy sale of genetic testing company 23andMe late on Monday, giving California three days to make its case that the sale should remain blocked during an ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder and former chief executive, Anne Wojcicki.